Eyre David E, Schlich George W
Schlich, 9 St Catherine's Road, Littlehampton, West Sussex, BN17 5HS, UK.
Pharm Pat Anal. 2015;4(6):431-41. doi: 10.4155/ppa.15.29.
Stem cells offer the prospect of treatments for diseases and injuries that are currently beyond medical science. Although development of these potential medical marvels has been dogged by their controversial origin, technological developments and guidance from recent judicial decisions have answered and overcome many of these difficulties. In particular, the European Patent Office, United States Patent and Trademark Office, Japan Patent Office and State Intellectual Property Office of China have published guidelines covering patenting of stem cell technologies in the light of recent decisions. We now see a patent landscape where stem cell technologies and related therapies can, with very few exceptions, be protected via patents, provided the appropriate form of claim wording is used.
干细胞为目前医学无法攻克的疾病和损伤带来了治疗前景。尽管这些潜在医学奇迹的发展一直因它们具有争议性的起源而受阻,但技术发展以及近期司法判决的指引已经解答并克服了其中许多困难。特别是,欧洲专利局、美国专利商标局、日本专利局和中国国家知识产权局已根据近期判决发布了涵盖干细胞技术专利申请的指南。我们现在看到的专利格局是,只要使用适当的权利要求措辞,干细胞技术及相关疗法几乎无一例外地都可以通过专利得到保护。